Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/36127
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCardoso, Matiaspt_PT
dc.contributor.authorGaspar, Vítor M.pt_PT
dc.contributor.authorFerreira, Carolinapt_PT
dc.contributor.authorSilvestre, Ricardopt_PT
dc.contributor.authorDuarte, Iola F.pt_PT
dc.contributor.authorMano, João F.pt_PT
dc.date.accessioned2023-01-31T10:45:07Z-
dc.date.available2023-01-31T10:45:07Z-
dc.date.issued2022-06-
dc.identifier.issn1549-9634pt_PT
dc.identifier.urihttp://hdl.handle.net/10773/36127-
dc.description.abstractThis study reports the formulation and delivery of hyaluronic acid-Zein (HA-Zein) nanogels loaded with Shikonin (SK) to selectively attenuate macrophage inflammasome. The self-assembled nanogels, produced by nanoprecipitation, exhibited high encapsulation efficiency, and were selectively internalized by human THP-1-derived macrophages without eliciting cytotoxic responses. Cell treatment with HA-Zein-SK nanogels before stimulation with LPS and Nigericin significantly suppressed caspase-1 activation and IL-1β production, indicating inflammasome inhibition. Importantly, HA-Zein-SK nanogels bioinstructed inflammasome activated macrophages towards an anti-inflammatory CD163highHLA-DRlow phenotype and led to a marked reduction in the release of pro-inflammatory mediators (TNF-α, IL-6 and IP-10). Extracellular metabolic profiling additionally revealed SK-mediated downregulation of cellular glycolytic activity, which was corroborated by a significant decrease of glycolytic genes transcription. All in all, our findings demonstrate the potential of bioactive SK-containing, self-assembled nanogels to modulate exacerbated responses in innate immune cells and, prospectively, in human tissues where NRLP3 inflammasome is abnormally activated upon injury or disease.pt_PT
dc.language.isoengpt_PT
dc.publisherElsevierpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50011%2F2020/PTpt_PT
dc.relationLA/P/0006/2020pt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F50011%2F2020/PTpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/FARH/SFRH%2FBD%2F139539%2F2018/PTpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/PD%2FBDE%2F127830%2F2016/PTpt_PT
dc.relationCEECIND/00185/2020pt_PT
dc.relationCEECIND/1048/2019pt_PT
dc.rightsrestrictedAccesspt_PT
dc.subjectInterleukin-1betapt_PT
dc.subjectMacrophagespt_PT
dc.subjectNLR Family, Pyrin Domain-Containing 3 Proteinpt_PT
dc.subjectNanogelspt_PT
dc.subjectNaphthoquinonespt_PT
dc.subjectInflammasomespt_PT
dc.subjectZeinpt_PT
dc.titleMacrophage-targeted shikonin-loaded nanogels for modulation of inflammasome activationpt_PT
dc.typearticlept_PT
dc.description.versionpublishedpt_PT
dc.peerreviewedyespt_PT
degois.publication.titleNanomedicine: Nanotechnology, Biology, and Medicinept_PT
degois.publication.volume42pt_PT
dc.identifier.doi10.1016/j.nano.2022.102548pt_PT
dc.identifier.essn1549-9642pt_PT
dc.identifier.articlenumber102548pt_PT
Appears in Collections:CICECO - Artigos

Files in This Item:
File Description SizeFormat 
Cardoso2022_Nanomedicine.pdf3.07 MBAdobe PDFrestrictedAccess


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.